The Prague Post - neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

EUR -
AED 4.243687
AFN 80.258579
ALL 97.948265
AMD 440.592197
ANG 2.067962
AOA 1058.465478
ARS 1362.804464
AUD 1.778285
AWG 2.082842
AZN 1.968988
BAM 1.955765
BBD 2.322859
BDT 140.58751
BGN 1.96051
BHD 0.433992
BIF 3425.439333
BMD 1.15553
BND 1.477574
BOB 7.949859
BRL 6.406145
BSD 1.15048
BTN 98.998247
BWP 15.463726
BYN 3.764933
BYR 22648.378878
BZD 2.310959
CAD 1.569961
CDF 3324.458889
CHF 0.938796
CLF 0.027884
CLP 1070.051049
CNY 8.298556
CNH 8.307576
COP 4778.715365
CRC 579.88973
CUC 1.15553
CUP 30.621533
CVE 110.263047
CZK 24.84493
DJF 204.866372
DKK 7.461301
DOP 67.948797
DZD 150.258339
EGP 57.438983
ERN 17.332943
ETB 155.208151
FJD 2.59792
FKP 0.851372
GBP 0.852443
GEL 3.166602
GGP 0.851372
GHS 11.84979
GIP 0.851372
GMD 81.469282
GNF 9968.823444
GTQ 8.840843
GYD 240.695737
HKD 9.070618
HNL 30.026468
HRK 7.537177
HTG 150.877328
HUF 402.707866
IDR 18834.322544
ILS 4.160155
IMP 0.851372
INR 99.58874
IQD 1507.073308
IRR 48647.793814
ISK 144.037202
JEP 0.851372
JMD 184.196738
JOD 0.819316
JPY 166.507229
KES 148.637368
KGS 101.051502
KHR 4612.918301
KMF 492.837731
KPW 1039.976573
KRW 1579.771091
KWD 0.353847
KYD 0.958683
KZT 590.089549
LAK 24822.560372
LBP 103080.774354
LKR 344.473899
LRD 230.095925
LSL 20.704233
LTL 3.411979
LVL 0.698969
LYD 6.285889
MAD 10.518914
MDL 19.701651
MGA 5194.907994
MKD 61.53391
MMK 2426.268419
MNT 4138.767016
MOP 9.301035
MRU 45.673191
MUR 52.588586
MVR 17.800977
MWK 1994.864669
MXN 21.910925
MYR 4.905805
MZN 73.89655
NAD 20.704233
NGN 1782.335411
NIO 42.33925
NOK 11.468204
NPR 158.397195
NZD 1.914238
OMR 0.444022
PAB 1.15048
PEN 4.152526
PGK 4.805915
PHP 64.814084
PKR 326.153924
PLN 4.273513
PYG 9179.837417
QAR 4.196726
RON 5.027136
RSD 117.197924
RUB 92.187067
RWF 1661.270578
SAR 4.337388
SBD 9.645657
SCR 16.420505
SDG 693.899733
SEK 10.950611
SGD 1.481278
SHP 0.908065
SLE 25.479855
SLL 24230.88081
SOS 657.488355
SRD 43.364756
STD 23917.128362
SVC 10.066822
SYP 15024.024763
SZL 20.690634
THB 37.444978
TJS 11.619594
TMT 4.044353
TND 3.40414
TOP 2.70637
TRY 45.493623
TTD 7.801862
TWD 34.111657
TZS 2973.947329
UAH 47.720955
UGX 4145.926572
USD 1.15553
UYU 47.299162
UZS 14617.741108
VES 118.057029
VND 30130.432615
VUV 137.626073
WST 3.026547
XAF 655.945383
XAG 0.031814
XAU 0.000336
XCD 3.122877
XDR 0.815786
XOF 655.945383
XPF 119.331742
YER 281.198532
ZAR 20.738243
ZMK 10401.156591
ZMW 27.812507
ZWL 372.080039
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

neurocare group AG, a best practice platform for mental health and performance, is pleased to announce the appointment of Kevin Reeder as Chief Financial Officer of the company, from January 1st 2025.

Text size:

neurocare group AG ("neurocare" or the "Company"), a best practice platform for mental health and performance, is pleased to announce the appointment of Kevin Reeder as Chief Financial Officer of the company, from January 1st 2025.

neurocare appoints Kevin Reeder as CFO starting January 2025

Kevin Reeder holds an MBA from Oxford University and is currently the CEO of the venture capital firm bm|t, one of neurocare´s largest investors. Kevin has a long history in international investment management both in the US and in Europe, spanning venture capital, private equity, and publicly traded investments.

Prior to joining bm|t, Kevin held key roles at INVESCO, Silvergate Capital, GVO Asset Management, and Bank am Bellevue. He also gained experience outside of the investment sector as Head of Data and Credit at M-KOPA, a high-growth company in Africa, where he led fundraising efforts, managed financial operations, and established the company's data analytics platform.

Kevin joined the neurocare board at the end of 2021 and played a key role in fundraising, strategy, and M&A. He will step aside from the board to fully focus on his responsibilities as CFO, driving financial strategy and supporting neurocare's growth initiatives.

"We are delighted to welcome Kevin Reeder as neurocare's new CFO. Having worked with Kevin since joining the board, I have developed a deep respect and admiration for him as a business leader who understands our business and vision. Kevin's exceptional expertise and longstanding familiarity with neurocare's goals make him an ideal fit to help drive our growth and deliver value to our stakeholders," said Tristan de Boysson, Chairman of the Supervisory Board.

"Kevin's appointment as CFO completes neurocare's Global Leadership Team at a time of such exciting growth for our innovative company," said Thomas Mechtersheimer, Founder & CEO of neurocare. "Having worked closely with Kevin as a Board member, I am confident that his deep understanding of our business will enable us to drive neurocare's growth faster right away. On a personal note, I am much looking forward to sharing my life's professional vision and purpose with someone so energetic and equally purpose driven."

"I am honored to step into the role of CFO at neurocare and to be part of such a forward-thinking company dedicated to transforming mental health and performance," said Kevin Reeder. "Having had the privilege of working with neurocare as a Board member, I have a deep appreciation for the team's vision and the positive impact we're making. I look forward to leveraging my experience to support neurocare's growth and financial strategy as we continue to expand our reach and become a global leader in mental healthcare."

Contact Information:

Sally Remington
Global Marketing Manager
[email protected]
+49 152 2305 8385

SOURCE: neurocare group AG

U.Pospisil--TPP